Search Results - "Rickard, Kathleen A."

Refine Results
  1. 1

    Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy by Fish, J E, Israel, E, Murray, J J, Emmett, A, Boone, R, Yancey, S W, Rickard, K A

    Published in Chest (01-08-2001)
    “…Comparison of inhaled salmeterol powder vs oral montelukast treatment in patients with persistent asthma who remained symptomatic while receiving inhaled…”
    Get more information
    Journal Article
  2. 2

    Fractional Exhaled Nitric Oxide (FeNO) Measurements with the NIOX VERO® in Children 4 to 6 Years Old using the 6 and 10 Second Exhalation Modes by Jain, Neal, Wasserman, Richard L., LaForce, Craig F., Anolik, Robert, MacDonald-Berko, Margot, Rickard, Kathleen A.

    Published in Journal of allergy and clinical immunology (01-02-2018)
    “…Rationale This study, conducted using the NIOX VERO, assessed the feasibility and degree of agreement between FeNO measurements performed in the same subject…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Lack of Subsensitivity to Albuterol After Treatment with Salmeterol in Patients with Asthma by NELSON, HAROLD S, BERKOWITZ, ROBERT B, TINKELMAN, DAVID A, EMMETT, AMANDA H, RICKARD, KATHLEEN A, YANCEY, STEVEN W

    “…The development of tolerance to the bronchodilator effects of beta2-agonists used in asthma therapy has been the subject of debate. We conducted two…”
    Get full text
    Journal Article
  5. 5

    Efficacy of salmeterol xinafoate in the treatment of COPD by Mahler, D A, Donohue, J F, Barbee, R A, Goldman, M D, Gross, N J, Wisniewski, M E, Yancey, S W, Zakes, B A, Rickard, K A, Anderson, W H

    Published in Chest (01-04-1999)
    “…To examine and compare the efficacy and safety of salmeterol xinafoate, a long-acting inhaled beta2-adrenergic agonist, with inhaled ipratropium bromide and…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma by Bleecker, Eugene R., Welch, Michael J., Weinstein, Steven F., Kalberg, Christopher, Johnson, Marty, Edwards, Lisa, Rickard, Kathleen A.

    Published in Journal of allergy and clinical immunology (01-06-2000)
    “…Background: Few studies have compared the efficacy of inhaled corticosteroids and leukotriene modifiers for the treatment of persistent asthma. Objective: Our…”
    Get full text
    Journal Article
  9. 9

    No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year by Allen, David B, Meltzer, Eli O, Lemanske, Jr, Robert F, Philpot, Edward E, Faris, Melissa A, Kral, Kenneth M, Prillaman, Barbara A, Rickard, Kathleen A

    Published in Allergy and asthma proceedings (01-11-2002)
    “…This randomized, double-blind, placebo-controlled study of fluticasone propionate aqueous nasal spray (at a maximum recommended dose of 200 micrograms each…”
    Get more information
    Journal Article
  10. 10
  11. 11

    The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis by DeWester, Jeffrey, Philpot, Edward E, Westlund, Ronald E, Cook, Cindy K, Rickard, Kathleen A

    Published in Allergy and asthma proceedings (01-09-2003)
    “…Intranasal corticosteroids have been shown to decrease ocular symptoms associated with allergic rhinitis as well as nasal symptoms. The primary objective of…”
    Get more information
    Journal Article
  12. 12

    Lack of Effect of Fluticasone Propionate Aqueous Nasal Spray on the Hypothalamic-Pituitary-Adrenal Axis in 2- and 3-Year-Old Patients by Galant, Stanley P, Melamed, Isaac R, Nayak, Anjuli S, Blake, Kathryn V, Prillaman, Barbara A, Reed, Kenneth D, Cook, Cindy K, Philpot, Edward E, Rickard, Kathleen A

    Published in Pediatrics (Evanston) (01-07-2003)
    “…Fluticasone propionate aqueous nasal spray (FP) at the highest recommended doses does not affect hypothalamic-pituitary-adrenal (HPA) axis function in adults…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age by Creticos, Peter, Knobil, Katharine, Edwards, Lisa D, Rickard, Kathleen A, Dorinsky, Paul

    Published in Annals of allergy, asthma, & immunology (01-04-2002)
    “…There are limited published data describing the relative efficacy of available treatment options in younger versus older patients with persistent asthma. To…”
    Get more information
    Journal Article
  19. 19

    Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma by Pearlman, David S, White, Martha V, Lieberman, Allen K, Pepsin, Pamela J, Kalberg, Chris, Emmett, Amanda, Bowers, Brian, Rickard, Kathleen A, Dorinsky, Paul

    Published in Annals of allergy, asthma, & immunology (01-02-2002)
    “…Asthma is a chronic disease characterized by inflammation and bronchoconstriction. Medications that are able to effectively treat both components are…”
    Get more information
    Journal Article
  20. 20

    Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia by Webb, D Robert, Meltzer, Eli O, Finn, Jr, Albert F, Rickard, Kathleen A, Pepsin, Pamela J, Westlund, Ronald, Cook, Cindy K

    Published in Annals of allergy, asthma, & immunology (01-04-2002)
    “…Although response to intranasal corticosteroid therapy has been reported in patients with nonallergic rhinitis with eosinophilic syndrome (NARES), efficacy…”
    Get more information
    Journal Article